SCART1
Scavenger receptor cysteine-rich domain-containing protein SCART1
Also known as: CD163c-alpha, SRCRM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4G0T1
- Gene
- SCART1
- Ensembl
- ENSG00000214279
- Chromosome
- 10
- Canonical length
- 1027 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in T cell mediated immunity. Located in brush border and cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1027 residues, UniProt reviewed canonical sequence.
>Q4G0T1|SCART1
1 MRAALWTLGL GPLLLNLWAV PIGGPGALRL AYRHSTCDGV VLVRHHGAWG YVCNQEWTLA
61 EASVVCRQLG CGPAVGAPKY VPLPGEMAQP WLHNVSCRGN ESSLWECSLG SWCQSPCPHA
121 WVVVALCSNG TFRELRLVKG RSPCAGLPEI RNVNGVDRLC VLHVEEAMVF CRELGCGPVL
181 QAPRRDVGVV RKYLACRGTE PTIRSCRLDN NFRSGCDLRL DAEVVCSGHT EARLVGGEHP
241 CAGRLEVTWG TVCDAALDLA TAHVVCRELQ CGAVVSTPEG ARFGRGSGPV WTEAFRCAGN
301 ESLLFHCPRG RGSQCGHGHD AGLRCSEFRM VNGSSSCEGR VEFQVQGSWA PLCATHWDIA
361 DATVLCHQLN CGNAVAAPGG GHFGDGDAAI WPDAFHCEGT ESYLWNCPVS TLGAPACAPG
421 NTASAVCSGL AHALRLREGQ SRCDGRVEVS LDGVWGRVLD DAWDLRGAGV VCRQLGCRGA
481 QQAYDAPAPS RGSVQVALSR VRCLGTETRL TQCNVSATLQ EPAGTSRDAG VVCSGEVGTA
541 SPMARRHGIP GALTLSLHRE PQGAAGRGAG ALHGGAWGTV CDDAWDLRDA HVVCRQLGCG
601 RALSALGAAH FGAGAGRIWL DELGCQGHES ALWQCPSAGW GRHDWRHKED AGVFCSESVA
661 LRLRGGTCCC AGWLDVFYNG TWGAMCSNAL KDLSLSIICK QLGCGVWGVG LAGEQALPLC
721 GHRDRLGGQH RVPQAAQLHS VAMPFPPMAP ALLRPSRAGL SEDRPQAAGE PLNCSSWLGC
781 PEEGALRVRG GEDRCSGRVE LWHAGSWGTV CDDGWDLADA EVVCRQLGCG RAVAALGAAA
841 FGPGSGPVWL DEVGCRGSEA SLWGCPAERW GRGDRAHEED AGVRCWEPGP GPPLPAAPFR
901 TFWVVSVVLG SLLGLLLLGL MAFLILPRVT QAMQRGLGRS EVSPGEAIYD VIGEMPPAGL
961 YEEIMEAEAV LQDEEDGSVV KVDTEAAVSG EVSNLLEGQS IRAEGGHSRP VSQGYDEAAF
1021 PLEEMTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCART1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 1 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 1 nTPM
- bone marrow: 0.8 nTPM
- skin: 0.8 nTPM
- epididymis: 0.7 nTPM
- spleen: 0.7 nTPM
- retina: 0.6 nTPM
Single-cell type
- innate lymphoid cells: 106 nCPM
- rod photoreceptor cells: 37 nCPM
- esophageal apical cells: 37 nCPM
- brain excitatory neurons: 35 nCPM
- adrenal medulla cells: 32 nCPM
- retinal bipolar cells: 32 nCPM
Immune cell
- MAIT T-cell: 0.2 nTPM
- basophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
Brain region
- cerebral cortex: 18 nTPM
- hippocampal formation: 18 nTPM
- cerebellum: 12 nTPM
- white matter: 10 nTPM
- pons: 9 nTPM
- basal ganglia: 8.9 nTPM
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCART1 as an antibody target. Whether an autoantibody or antibody against SCART1 could matter depends on whether native SCART1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCART1 is annotated at the cell surface, where native SCART1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SCART1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...